Funding 2 Programme Date definition

Funding 2 Programme Date means 19 January, 2005;
Sample 1Sample 2Sample 3
Funding 2 Programme Date. On the Funding 2 Programme Date, the Seller shall deliver to each Funding Security Trustee, each Funding Beneficiary and the Mortgages Trustee or the representative of such party (or procure such delivery to such party) an original power of attorney in the form set out in Part 2 of Schedule 10 (Power of Attorney in favour of the Mortgages Trustee, Funding, Funding 2, the Security Trustee and the Funding 2 Security Trustee) duly executed by the Seller. On the delivery of such power of attorney in accordance with the previous sentence, the parties hereto agree that the power of attorney delivered by the Seller on 26 March 2001 in accordance with Clause 3.1(a) shall terminate and be of no further effect.
Sample 1

Examples of Funding 2 Programme Date in a sentence

  • Chemical Physics aims to explain structure and dynamics of molecular and bulk systems in terms of atomic and molecular interactions.

  • The Issuer Cash Manager undertakes (to the extent to which the same is within its control in its capacity as Issuer Cash Manager) that at the Funding 2 Programme Date the Issuer Bank Accounts will be operative and that the Issuer Cash Manager will not knowingly create or permit to subsist any Security Interest in relation to the Issuer Bank Accounts other than as created under or permitted pursuant to the Issuer Deed of Charge.

  • References herein to the "Funding 2 Share" shall, from (and including) the Funding 2 Programme Date to (but excluding) the first Closing Date in relation to the issue of Notes by a Funding 2 Issuer, mean the Initial Funding 2 Share and thereafter shall mean the Current Funding 2 Share.

  • The Mortgage Trustee holds the assigned mortgage loans as bare trustee for Funding 1, the Seller and following the Funding 2 Programme Date, Funding 2, pursuant to the terms of the Mortgages Trust Deed.

Related to Funding 2 Programme Date

  • Programme Date means the date of this Base Prospectus.

  • Funding Period means the period beginning on the Closing Date and ending on the first to occur of (a) the Distribution Date on which the amount on deposit in the Pre-Funding Account (after giving effect to any transfers therefrom in connection with the transfer of Subsequent Contracts to the Trust on such Distribution Date) is less than $150,000, (b) the date on which an Event of Termination occurs, (c) the date on which an Insolvency Event occurs with respect to the Trust Depositor and (d) the close of business on the date which is 90 days from and including the Closing Date.

  • Development Period Security shall have the meaning set forth in Section 6.1(a) hereof.

  • Scheduled Commercial Operation Date shall have the meaning ascribed to it in Clause 5.4.1;

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Amortization Commencement Date means the date on which an Amortization Event is deemed to occur pursuant to Section 20 hereof.

  • Activation Date means the date upon which MLBFS shall cause the WCMA Line of Credit to be fully activated under MLPF&S' computer system as part of the WCMA Program.

  • Distribution Commencement Date means the Issue Date or such other date as may be specified as the Distribution Commencement Date on the face of such Perpetual Security;

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Scheduled Completion Date shall be the date set forth in Clause 10.3;

  • Draw Date means, with respect to any Insured Distribution Date, the third Business Day immediately preceding such Insured Distribution Date.

  • Phase II Clinical Trial means a study in humans of the safety, dose ranging and efficacy of a product, which is prospectively designed to generate sufficient data (if successful) to commence a Phase III Clinical Trial or to file for accelerated approval, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(b) or its foreign equivalents.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Development Period means the period from the date of this Agreement until the Appointed Date;

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Accumulation Commencement Date means January 1, 2021, or such later date as the Calculation Agent on behalf of the Issuer determines in accordance with Section 2.11 hereof.